开云app官网登录入口网页版-官方正版

#药物联合#

43篇内容 | 1647人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2211555, encodeId=b274221155510, content=<a href='/topic/show?id=bd828e850c1' target=_blank style='color:#2F92EE;'>#药物联合#</a> <a href='/topic/show?id=42cb330513c' target=_blank style='color:#2F92EE;'>#加速康复外科#</a> <a href='/topic/show?id=60e31152e052' target=_blank style='color:#2F92EE;'>#多模式镇痛#</a> <a href='/topic/show?id=886411585609' target=_blank style='color:#2F92EE;'>#镇痛方法#</a>, objectTitle=多模式镇痛方法大全, objectType=article, longId=831602, objectId=c279831602a6, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240625/1719283436158_5579292.jpg, objectUrl=/article/show_article.do?id=c279831602a6, replyNumber=0, likeNumber=67, createdTime=2024-06-25, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=c279831602a6, moduleTitle=多模式镇痛方法大全, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c279831602a6)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1997454, encodeId=046d199e45472, content=<a href='/topic/show?id=bd828e850c1' target=_blank style='color:#2F92EE;'>#药物联合#</a>, objectTitle=【每日播报】-磺脲类药物联合噻唑烷二酮类药物的疗效, objectType=article, longId=738849, objectId=ad8fe388491a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad8fe388491a, replyNumber=0, likeNumber=94, createdTime=2022-10-05, rootId=0, userName=sjzlzc007, userId=917c196, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad8fe388491a, moduleTitle=【每日播报】-磺脲类药物联合噻唑烷二酮类药物的疗效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=ad8fe388491a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997451, encodeId=8cb0199e451d5, content=<a href='/topic/show?id=bd828e850c1' target=_blank style='color:#2F92EE;'>#药物联合#</a>, objectTitle= Neurology：抗癫痫药物联合治疗胶质瘤的多中心队列研究, objectType=article, longId=733934, objectId=4cbde339348a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4cbde339348a, replyNumber=0, likeNumber=89, createdTime=2022-12-22, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4cbde339348a, moduleTitle= Neurology：抗癫痫药物联合治疗胶质瘤的多中心队列研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=4cbde339348a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997452, encodeId=3bde199e45254, content=<a href='/topic/show?id=bd828e850c1' target=_blank style='color:#2F92EE;'>#药物联合#</a>, objectTitle=中国真实世界经验-不耐受强化疗的老年AML患者，去甲基化药物联合低剂量化疗预后佳, objectType=article, longId=734613, objectId=49dce34613fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=49dce34613fc, replyNumber=0, likeNumber=81, createdTime=2022-09-04, rootId=0, userName=sjzlzc007, userId=917c196, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=49dce34613fc, moduleTitle=中国真实世界经验-不耐受强化疗的老年AML患者，去甲基化药物联合低剂量化疗预后佳, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=49dce34613fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997456, encodeId=2c5f199e4567d, content=<a href='/topic/show?id=bd828e850c1' target=_blank style='color:#2F92EE;'>#药物联合#</a>, objectTitle=【每日播报】-磺脲类药物联合DPP-4抑制剂的疗效, objectType=article, longId=738851, objectId=9b3ae388512b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b3ae388512b, replyNumber=0, likeNumber=83, createdTime=2022-12-09, rootId=0, userName=sjzlzc007, userId=917c196, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b3ae388512b, moduleTitle=【每日播报】-磺脲类药物联合DPP-4抑制剂的疗效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9b3ae388512b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997455, encodeId=98b1199e455ea, content=<a href='/topic/show?id=bd828e850c1' target=_blank style='color:#2F92EE;'>#药物联合#</a>, objectTitle=【每日播报】-磺脲类药物联合α-糖苷酶抑制剂的疗效, objectType=article, longId=738850, objectId=a364e388504c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a364e388504c, replyNumber=0, likeNumber=68, createdTime=2023-08-06, rootId=0, userName=sjzlzc007, userId=917c196, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a364e388504c, moduleTitle=【每日播报】-磺脲类药物联合α-糖苷酶抑制剂的疗效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a364e388504c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997453, encodeId=1bc5199e45326, content=<a href='/topic/show?id=bd828e850c1' target=_blank style='color:#2F92EE;'>#药物联合#</a>, objectTitle=【每日播报】-磺脲类药物联合二甲双胍疗效, objectType=article, longId=738848, objectId=2759e388489a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2759e388489a, replyNumber=0, likeNumber=72, createdTime=2023-08-05, rootId=0, userName=sjzlzc007, userId=917c196, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2759e388489a, moduleTitle=【每日播报】-磺脲类药物联合二甲双胍疗效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=2759e388489a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997449, encodeId=df15199e44904, content=<a href='/topic/show?id=bd828e850c1' target=_blank style='color:#2F92EE;'>#药物联合#</a>, objectTitle=GUT: 与维多珠单抗单药治疗相比，维多珠单抗和硫嘌呤类药物联合治疗克罗恩病失效的风险更低, objectType=article, longId=723921, objectId=e27de239212b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e27de239212b, replyNumber=0, likeNumber=100, createdTime=2023-01-13, rootId=0, userName=sjzlzc007, userId=917c196, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e27de239212b, moduleTitle=GUT: 与维多珠单抗单药治疗相比，维多珠单抗和硫嘌呤类药物联合治疗克罗恩病失效的风险更低, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e27de239212b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997445, encodeId=4ae0199e44569, content=<a href='/topic/show?id=bd828e850c1' target=_blank style='color:#2F92EE;'>#药物联合#</a>, objectTitle=Sci Transl Med：mRNA纳米药物联合PD-1，显著提高癌症治疗效果, objectType=article, longId=213428, objectId=094321342862, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=094321342862, replyNumber=0, likeNumber=107, createdTime=2021-07-05, rootId=0, userName=sjzlzc007, userId=917c196, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=094321342862, moduleTitle=Sci Transl Med：mRNA纳米药物联合PD-1，显著提高癌症治疗效果, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=094321342862)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997448, encodeId=df86199e4482e, content=<a href='/topic/show?id=bd828e850c1' target=_blank style='color:#2F92EE;'>#药物联合#</a>, objectTitle=JAAD:抗组胺药物联合局部皮质类固醇和表面冷冻治疗斑秃的疗效分析, objectType=article, longId=217198, objectId=1c8821e198fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c8821e198fa, replyNumber=0, likeNumber=73, createdTime=2021-09-21, rootId=0, userName=sjzlzc007, userId=917c196, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c8821e198fa, moduleTitle=JAAD:抗组胺药物联合局部皮质类固醇和表面冷冻治疗斑秃的疗效分析, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=1c8821e198fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997447, encodeId=f838199e44791, content=<a href='/topic/show?id=bd828e850c1' target=_blank style='color:#2F92EE;'>#药物联合#</a>, objectTitle=PlOS MED：阿片类药物与催眠药物联合使用，死亡风险极具增加！, objectType=article, longId=214385, objectId=6d53214385c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d53214385c6, replyNumber=0, likeNumber=75, createdTime=2021-09-14, rootId=0, userName=sjzlzc007, userId=917c196, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d53214385c6, moduleTitle=PlOS MED：阿片类药物与催眠药物联合使用，死亡风险极具增加！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=6d53214385c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997446, encodeId=d787199e446f7, content=<a href='/topic/show?id=bd828e850c1' target=_blank style='color:#2F92EE;'>#药物联合#</a>, objectTitle=免疫药物联合化疗，晚期鼻咽癌患者可获更长生存期, objectType=article, longId=213487, objectId=2d6121348ebe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d6121348ebe, replyNumber=0, likeNumber=102, createdTime=2021-08-11, rootId=0, userName=sjzlzc007, userId=917c196, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d6121348ebe, moduleTitle=免疫药物联合化疗，晚期鼻咽癌患者可获更长生存期, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=2d6121348ebe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997442, encodeId=f6a8199e442f0, content=<a href='/topic/show?id=bd828e850c1' target=_blank style='color:#2F92EE;'>#药物联合#</a>, objectTitle=BMJ：不同生物药物联合甲氨蝶呤治疗类风湿关节炎的疗效差异研究, objectType=article, longId=197377, objectId=c1ab19e3772b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c1ab19e3772b, replyNumber=0, likeNumber=69, createdTime=2020-12-04, rootId=0, userName=sjzlzc007, userId=917c196, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c1ab19e3772b, moduleTitle=BMJ：不同生物药物联合甲氨蝶呤治疗类风湿关节炎的疗效差异研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c1ab19e3772b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997444, encodeId=3b2d199e44402, content=<a href='/topic/show?id=bd828e850c1' target=_blank style='color:#2F92EE;'>#药物联合#</a>, objectTitle=Lancet Neurology：未破裂脑动静脉畸形（ARUBA）药物联合介入治疗与单纯药物治疗的比较：一项多中心、非盲、随机对照试验的最终随访, objectType=article, longId=203855, objectId=0b5d20385538, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b5d20385538, replyNumber=0, likeNumber=94, createdTime=2021-05-14, rootId=0, userName=sjzlzc007, userId=917c196, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b5d20385538, moduleTitle=Lancet Neurology：未破裂脑动静脉畸形（ARUBA）药物联合介入治疗与单纯药物治疗的比较：一项多中心、非盲、随机对照试验的最终随访, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=0b5d20385538)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997443, encodeId=b21c199e443cd, content=<a href='/topic/show?id=bd828e850c1' target=_blank style='color:#2F92EE;'>#药物联合#</a>, objectTitle=EUR HEART J-CARD PHA：与利尿剂和心率或心律控制药物联合治疗的房颤患者血清钾水平与短期死亡率的关系如何？, objectType=article, longId=198582, objectId=e1ef198582c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1ef198582c3, replyNumber=0, likeNumber=92, createdTime=2020-10-18, rootId=0, userName=sjzlzc007, userId=917c196, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1ef198582c3, moduleTitle=EUR HEART J-CARD PHA：与利尿剂和心率或心律控制药物联合治疗的房颤患者血清钾水平与短期死亡率的关系如何？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e1ef198582c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997441, encodeId=d7f8199e44113, content=<a href='/topic/show?id=bd828e850c1' target=_blank style='color:#2F92EE;'>#药物联合#</a>, objectTitle=Lancet：新靶点药物联合应用有望大幅降低心衰患者死亡风险, objectType=article, longId=194578, objectId=05331945e8d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=05331945e8d6, replyNumber=0, likeNumber=77, createdTime=2021-04-26, rootId=0, userName=sjzlzc007, userId=917c196, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=05331945e8d6, moduleTitle=Lancet：新靶点药物联合应用有望大幅降低心衰患者死亡风险, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=05331945e8d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997440, encodeId=d704199e44039, content=<a href='/topic/show?id=bd828e850c1' target=_blank style='color:#2F92EE;'>#药物联合#</a>, objectTitle=Sci Adv：白血病药物联合PD-1抑制剂增强免疫治疗效果！, objectType=article, longId=161048, objectId=33fa161048ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33fa161048ff, replyNumber=0, likeNumber=86, createdTime=2019-07-28, rootId=0, userName=sjzlzc007, userId=917c196, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33fa161048ff, moduleTitle=Sci Adv：白血病药物联合PD-1抑制剂增强免疫治疗效果！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=33fa161048ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997439, encodeId=0174199e439b7, content=<a href='/topic/show?id=bd828e850c1' target=_blank style='color:#2F92EE;'>#药物联合#</a>, objectTitle=Int J Cardiol：类固醇和类固醇加免疫抑制药物联合对心脏结节病的疗效比较, objectType=article, longId=154960, objectId=bbc21549600c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bbc21549600c, replyNumber=0, likeNumber=89, createdTime=2018-12-15, rootId=0, userName=sjzlzc007, userId=917c196, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bbc21549600c, moduleTitle=Int J Cardiol：类固醇和类固醇加免疫抑制药物联合对心脏结节病的疗效比较, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=bbc21549600c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997437, encodeId=6016199e43707, content=<a href='/topic/show?id=bd828e850c1' target=_blank style='color:#2F92EE;'>#药物联合#</a>, objectTitle=美国糖尿病协会发布几种药物联合管理糖尿病，效果远超二甲双胍, objectType=article, longId=129886, objectId=48d412988684, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=48d412988684, replyNumber=0, likeNumber=131, createdTime=2018-05-12, rootId=0, userName=sjzlzc007, userId=917c196, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=48d412988684, moduleTitle=美国糖尿病协会发布几种药物联合管理糖尿病，效果远超二甲双胍, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=48d412988684)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997438, encodeId=ab7e199e438fc, content=<a href='/topic/show?id=bd828e850c1' target=_blank style='color:#2F92EE;'>#药物联合#</a>, objectTitle=PNAS重磅：100%的黑色素瘤完全消失！只需这两种药物联合使用！, objectType=article, longId=147968, objectId=9c2214e96805, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c2214e96805, replyNumber=0, likeNumber=83, createdTime=2019-06-10, rootId=0, userName=sjzlzc007, userId=917c196, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c2214e96805, moduleTitle=PNAS重磅：100%的黑色素瘤完全消失！只需这两种药物联合使用！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9c2214e96805)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

药物联合

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#药物联合# #加速康复外科# #多模式镇痛# #镇痛方法#

多模式镇痛方法大全

2024-06-25发表于上海

sjzlzc007 (审核中...)

前往app查看评论内容

#药物联合#

【每日播报】-磺脲类药物联合噻唑烷二酮类药物的疗效

2022-10-05

医者仁心 (审核中...)

前往app查看评论内容

#药物联合#

Neurology：抗癫痫药物联合治疗胶质瘤的多中心队列研究

2022-12-22

sjzlzc007 (审核中...)

前往app查看评论内容

#药物联合#

中国真实世界经验-不耐受强化疗的老年AML患者，去甲基化药物联合低剂量化疗预后佳

2022-09-04

sjzlzc007 (审核中...)

前往app查看评论内容

#药物联合#

【每日播报】-磺脲类药物联合DPP-4抑制剂的疗效

2022-12-09

sjzlzc007 (审核中...)

前往app查看评论内容

#药物联合#

【每日播报】-磺脲类药物联合α-糖苷酶抑制剂的疗效

2023-08-06

sjzlzc007 (审核中...)

前往app查看评论内容

#药物联合#

【每日播报】-磺脲类药物联合二甲双胍疗效

2023-08-05

sjzlzc007 (审核中...)

前往app查看评论内容

#药物联合#

GUT: 与维多珠单抗单药治疗相比，维多珠单抗和硫嘌呤类药物联合治疗克罗恩病失效的风险更低

2023-01-13

sjzlzc007 (审核中...)

前往app查看评论内容

#药物联合#

Sci Transl Med：mRNA纳米药物联合PD-1，显著提高癌症治疗效果

2021-07-05

sjzlzc007 (审核中...)

前往app查看评论内容

#药物联合#

JAAD:抗组胺药物联合局部皮质类固醇和表面冷冻治疗斑秃的疗效分析

2021-09-21

sjzlzc007 (审核中...)

前往app查看评论内容

#药物联合#

PlOS MED：阿片类药物与催眠药物联合使用，死亡风险极具增加！

2021-09-14

sjzlzc007 (审核中...)

前往app查看评论内容

#药物联合#

免疫药物联合化疗，晚期鼻咽癌患者可获更长生存期

2021-08-11

sjzlzc007 (审核中...)

前往app查看评论内容

#药物联合#

BMJ：不同生物药物联合甲氨蝶呤治疗类风湿关节炎的疗效差异研究

2020-12-04

sjzlzc007 (审核中...)

前往app查看评论内容

#药物联合#

Lancet Neurology：未破裂脑动静脉畸形（ARUBA）药物联合介入治疗与单纯药物治疗的比较：一项多中心、非盲、随机对照试验的最终随访

2021-05-14

sjzlzc007 (审核中...)

前往app查看评论内容

#药物联合#

EUR HEART J-CARD PHA：与利尿剂和心率或心律控制药物联合治疗的房颤患者血清钾水平与短期死亡率的关系如何？

2020-10-18

sjzlzc007 (审核中...)

前往app查看评论内容

#药物联合#

Lancet：新靶点药物联合应用有望大幅降低心衰患者死亡风险

2021-04-26

sjzlzc007 (审核中...)

前往app查看评论内容

#药物联合#

Sci Adv：白血病药物联合PD-1抑制剂增强免疫治疗效果！

2019-07-28

sjzlzc007 (审核中...)

前往app查看评论内容

#药物联合#

Int J Cardiol：类固醇和类固醇加免疫抑制药物联合对心脏结节病的疗效比较

2018-12-15

sjzlzc007 (审核中...)

前往app查看评论内容

#药物联合#

美国糖尿病协会发布几种药物联合管理糖尿病，效果远超二甲双胍

2018-05-12

sjzlzc007 (审核中...)

前往app查看评论内容

#药物联合#

PNAS重磅：100%的黑色素瘤完全消失！只需这两种药物联合使用！

2019-06-10

科室
- - 订阅+
  - 更多科室
工具
服务